Government ❯Regulatory Agencies ❯FDA
Public Health Compounding Regulations Public Health Regulations MDMA for PTSD Insulin Icodec MDMA Approval Psychedelic Drugs Clinical Trials Clinical Trial Regulations Ranitidine Regulations Medication Safety Over-the-Counter Medications Accelerated Approval Tirzepatide Supply Breakthrough Therapy Designation Mifepristone Legislation Compliance Animal Welfare Policies Ethical Standards in Testing Animal Welfare Clinical Data Requirements Enforcement Actions Biotech Innovation Safety Concerns Mifepristone Review Clinical Study Regulations Safety Communications Market Withdrawal Risks MDMA MDMA Trials Alzheimer's Drug Approval
Two teenage deaths within 90 days of infusion prompted Sarepta to suspend shipments to non-ambulatory patients.